全文获取类型
收费全文 | 485044篇 |
免费 | 34628篇 |
国内免费 | 12712篇 |
专业分类
耳鼻咽喉 | 5213篇 |
儿科学 | 11718篇 |
妇产科学 | 7098篇 |
基础医学 | 44777篇 |
口腔科学 | 9698篇 |
临床医学 | 56725篇 |
内科学 | 74442篇 |
皮肤病学 | 5526篇 |
神经病学 | 28247篇 |
特种医学 | 21301篇 |
外国民族医学 | 34篇 |
外科学 | 63483篇 |
综合类 | 56797篇 |
现状与发展 | 48篇 |
一般理论 | 13篇 |
预防医学 | 38133篇 |
眼科学 | 7305篇 |
药学 | 54116篇 |
288篇 | |
中国医学 | 21399篇 |
肿瘤学 | 26023篇 |
出版年
2023年 | 6029篇 |
2022年 | 9102篇 |
2021年 | 19814篇 |
2020年 | 16187篇 |
2019年 | 20428篇 |
2018年 | 15503篇 |
2017年 | 15633篇 |
2016年 | 17596篇 |
2015年 | 19581篇 |
2014年 | 32126篇 |
2013年 | 34122篇 |
2012年 | 33166篇 |
2011年 | 32359篇 |
2010年 | 25863篇 |
2009年 | 25439篇 |
2008年 | 25303篇 |
2007年 | 26254篇 |
2006年 | 23423篇 |
2005年 | 18413篇 |
2004年 | 13027篇 |
2003年 | 11465篇 |
2002年 | 9279篇 |
2001年 | 8002篇 |
2000年 | 6759篇 |
1999年 | 5336篇 |
1998年 | 4605篇 |
1997年 | 4453篇 |
1996年 | 3957篇 |
1995年 | 3933篇 |
1994年 | 3746篇 |
1993年 | 3078篇 |
1992年 | 3088篇 |
1991年 | 2830篇 |
1990年 | 2630篇 |
1989年 | 2346篇 |
1988年 | 2189篇 |
1987年 | 2003篇 |
1986年 | 1741篇 |
1985年 | 3010篇 |
1984年 | 2843篇 |
1983年 | 2081篇 |
1982年 | 2209篇 |
1981年 | 2021篇 |
1980年 | 1804篇 |
1979年 | 1491篇 |
1978年 | 1094篇 |
1977年 | 1048篇 |
1976年 | 944篇 |
1975年 | 631篇 |
1974年 | 615篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Klaus Schneider Marco Dilger Claudia Drossard Heidi Ott Eva Kaiser 《Journal of applied toxicology : JAT》2022,42(5):913-926
Frameworks for deriving occupational exposure limits (OELs) and OEL-analogue values (such as derived-no-effect levels [DNELs]) in various regulatory areas in the EU and at national level in Germany were analysed. Reasons for differences between frameworks and possible means of improving transparency and harmonisation were identified. Differences between assessment factors used for deriving exposure limits proved to be one important reason for diverging numerical values. Distributions for exposure time, interspecies and intraspecies extrapolation were combined by probabilistic methods and compared with default values of assessment factors used in the various OEL frameworks in order to investigate protection levels. In a subchronic inhalation study showing local effects in the respiratory tract, the probability that assessment factors were sufficiently high to protect 99% and 95% of the target population (workers) from adverse effects varied considerably from 9% to 71% and 17% to 87%, respectively, between the frameworks. All steps of the derivation process, including the uncertainty associated with the point of departure (POD), were further analysed with two examples of full probabilistic assessments. It is proposed that benchmark modelling should be the method of choice for deriving PODs and that all OEL frameworks should provide detailed guidance documents and clearly define their protection goals by stating the proportion of the exposed population the OEL aims to cover and the probability with which they intend to provide protection from adverse effects. Harmonisation can be achieved by agreeing on the way to perform the methodological steps for deriving OELs and on common protection goals. 相似文献
102.
《Vaccine》2022,40(24):3380-3388
BackgroundWe evaluated the safety and immunogenicity of NVX-CoV2373, a recombinant SARS-CoV-2 nanoparticle vaccine, in healthy Japanese participants.MethodsThis phase 1/2, randomized, observer-blind, placebo-controlled trial conducted in Japan (two sites), enrolled healthy Japanese adults aged ≥ 20 years with no history/risk of SARS-CoV-2 infection and no prior exposure to other approved/investigational SARS-CoV-2 vaccines or treatments. Participants were stratified by age (< 65 or ≥ 65 years) and randomized to receive two doses of either NVX-CoV2373 (5 μg SARS-CoV-2 rS; 50 μg Matrix-M1) or placebo, 21 days apart. Primary outcomes were safety and immunogenicity assessed by serum IgG antibody levels against SARS-CoV-2 rS protein on day 36. Herein, we report the primary data analysis at 4 weeks after the second dose, ahead of 12-month follow-up completion (data cut-off: 8 May 2021).ResultsBetween 12 February 2021 and 17 March 2021, 326 subjects were screened, and 200 participants enrolled and randomized: NVX-CoV2373, n = 150; placebo, n = 50. Solicited adverse events (AEs) through 7 days after each injection occurred in 121/150 (80.7%) and 11/50 (22.0%) participants in the NVX-CoV2373 and placebo arms, respectively. In the NVX-CoV2373 arm, tenderness and injection site pain were the most frequently reported solicited AEs after each vaccination, irrespective of age. Robust immune responses occurred with NVX-CoV2373 (n = 150) by day 36: IgG geometric mean fold rise (95% confidence interval) 259 (219, 306); seroconversion rate 100% (97.6, 100). No such response occurred with placebo (n = 49).ConclusionTwo doses of NVX-CoV2373 given with a 21-day interval demonstrated acceptable safety and induced robust anti-SARS-CoV-2 immune responses in healthy Japanese adults. Funding: Takeda Pharmaceutical Company Limited and Japan Agency for Medical Research and Development (AMED). ClinicalTrials.gov identifier: NCT04712110. 相似文献
103.
一测多评法(quantitative analysis of multi-components by single marker,QAMS)已成熟应用于中药材、中药提取物及中成药领域等中药复杂体系的质量评价研究中,有效解决了因对照品缺乏而导致的多指标质控技术推广难问题。本文查阅近五年的国内外研究文献,重点总结了高效液相色谱、气相色谱和质谱等技术在QAMS法中药质量控制中的应用。高效液相色谱联用紫外检测器(UV)技术应用最为广泛,最适合于中药QAMS法定量,结果稳定、准确;而高效液相色谱联用蒸发光检测器在中药QAMS法应用中,其测定准确性和适用性仍然需进一步探索和验证。液质联用技术虽然具有灵敏度高、线性范围宽等优点,但易受仪器参数、基质效应等的影响。进一步发展HPLC-UV技术在中成药制剂质量评价中的应用,是QAMS法多成分定量值得关注的方向;探索LC-MS和GC技术在中药QAMS质量评价中的稳定性和普适性是未来将面临的挑战。 相似文献
104.
儿童哮喘与慢性阻塞性肺疾病(COPD)是儿童期与成人期常见的存在气流受限的慢性气道疾病。研究发现,儿童哮喘会增加成年期罹患COPD的风险,而肺功能变化是预测COPD患病风险的重要指标。针对哮喘患儿建立长期肺功能监测管理,对于评估其成年后存在不可逆气道阻塞的风险有重要意义。文章综述儿童哮喘与COPD相关的研究进展。 相似文献
106.
107.
108.
Manyu Gu Shuyi Wang Wandi Cao Dejian Yan Yi Cao 《Journal of applied toxicology : JAT》2022,42(4):651-659
Recently, we reported that titanium dioxide (TiO2) materials activated endothelial cells via Kruppel-like factor (KLF)-mediated nitric oxide (NO) dysfunction, but the roles of physical properties of materials are not clear. In this study, we prepared nanobelts from P25 particles and compared their adverse effects to human umbilical vein endothelial cells (HUVECs). TiO2 nanobelts had belt-like morphology but comparable surface areas as P25 particles. When applied to HUVECs, P25 particles or nanobelts did not induce cytotoxicity, although nanobelts were much more effective to increase intracellular Ti element concentrations compared the same amounts of P25 particles. Only nanobelts significantly induced THP-1 adhesion onto HUVECs. Consistently, nanobelts were more significant to induce the expression of intracellular adhesion molecule-1 (ICAM1) and the release of soluble ICAM-1 (sICAM-1), indicating that nanobelts were more potent to induce endothelial activation in vitro. As the mechanisms for endothelial activation, both P25 and nanobelts reduced the generation of intracellular NO as well as the expression of NO regulators KLF2 and KLF4. Combined, the results from this study indicated that the different morphologies of P25 particles and nanobelts only changed their internalization into HUVECs but showed minimal impact on KLF-mediated NO signaling pathways. 相似文献
109.
《Vaccine》2022,40(52):7515-7519
The recent wave of COVID-19 cases has led to the potential need for booster doses. We surveyed 6,294 people and found that 87.6% reported willingness to take a booster dose, with vaccine efficacy rate being the most common reason cited to accept booster dose. Differences in acceptance rates were noted among those working in non-health related sectors, different ethnic groups as well as those who had taken viral vector vaccines. 相似文献
110.